Matthew S. Tremblay

2.4k total citations · 1 hit paper
28 papers, 1.8k citations indexed

About

Matthew S. Tremblay is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Matthew S. Tremblay has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Matthew S. Tremblay's work include Pancreatic function and diabetes (6 papers), Lanthanide and Transition Metal Complexes (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Matthew S. Tremblay is often cited by papers focused on Pancreatic function and diabetes (6 papers), Lanthanide and Transition Metal Complexes (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Matthew S. Tremblay collaborates with scholars based in United States, Germany and China. Matthew S. Tremblay's co-authors include Dalibor Sameš, Peter G. Schultz, Marlin Halim, Xu Wu, Charles Y. Cho, Kristen Johnson, Jianing Wang, Shoutian Zhu, Alana Althage and Joshua N. Payette and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Matthew S. Tremblay

28 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Stem Cell–Based Approach to Cartilage Repair

2012 645 citations Kristen Johnson, Shoutian Zhu et al. Science profile →

Peers

Countries citing papers authored by Matthew S. Tremblay

Since Specialization

Citations

This map shows the geographic impact of Matthew S. Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Tremblay more than expected).

Fields of papers citing papers by Matthew S. Tremblay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Tremblay. The network helps show where Matthew S. Tremblay may publish in the future.

Co-authorship network of co-authors of Matthew S. Tremblay

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Tremblay. A scholar is included among the top collaborators of Matthew S. Tremblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Tremblay. Matthew S. Tremblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A small molecule UPR modulator for diabetes identified by high throughput screening 2021 ·Acta Pharmaceutica Sinica B ·(unknown), Tuan Anh Tran, Siying Zhu, Seung‐Hyuk Choi, Ana M. Gamo, Sijia Li, Qiangwei Fu, (unknown), Jason Roland, Mitchell Hull, Vân Nguyên-Trân, Sean B. Joseph, Arnab K. Chatterjee, Nikki Lynn Rogers, Matthew S. Tremblay, Weijun Shen	11
2	Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity 2020 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), David Huang, (unknown), Vân Nguyên-Trân, Sean B. Joseph, Shane Roller, Scott Peterson, (unknown), Matthew S. Tremblay, Peter G. Schultz, Weijun Shen	19
3	Development of KA34 as a cartilage regenerative therapy for Osteoarthritis 2020 ·Osteoarthritis and Cartilage ·Kenneth A. Johnson, (unknown), (unknown), Arnab K. Chatterjee, Shoutian Zhu, (unknown), (unknown), Jiancheng Li, Martin Lotz, Matthew S. Tremblay, Peter G. Schultz	9
4	Design of a Long-Acting and Selective MEG-Fatty Acid Stapled Prolactin-Releasing Peptide Analog 2019 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Shan Yu, Huafei Zou, (unknown), Sean B. Joseph, Vân Nguyên-Trân, Matthew S. Tremblay, Weijun Shen	12
5	Discovery of 5-(3,4-Difluorophenyl)-3-(pyrazol-4-yl)-7-azaindole (GNF3809) for β-Cell Survival in Type 1 Diabetes 2019 ·ACS Omega ·Zhihong Huang, Matthew S. Tremblay, Tom Wu, Qiang Ding, Xueshi Hao, (unknown), Robert Hill, Bo Liu, Shelly Meeusen, (unknown), Shanshan Yan, Yong Jia, Vân Nguyên-Trân, Weijun Shen, Ganesh Bhat, Richard Glynne, Bryan Laffitte, Jinhong Li, Valentina Molteni, Yahu A. Liu	9
6	Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes 2019 ·Cell Death Discovery ·Amin Ardestani, Matthew S. Tremblay, Weijun Shen, Kathrin Maedler	13
7	Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP in macrophages 2018 ·Proceedings of the National Academy of Sciences ·Evan D. Muse, Shan Yu, Chantle Edillor, Jenhan Tao, Nathanael J. Spann, Ty D. Troutman, Jason S. Seidman, Adam Henke, Jason Roland, (unknown), Bonne M. Thompson, Jeffrey G. McDonald, John Bahadorani, Sotirios Tsimikas, Tamar R. Grossman, Matthew S. Tremblay, Christopher K. Glass	86
8	The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis 2018 ·Proceedings of the National Academy of Sciences ·Jeff Janes, (unknown), Emily Chen, Nicole H. Rogers, Sebastian Burgstaller-Muehlbacher, Laura D. Hughes, Melissa S. Love, Mitchell Hull, Kelli Kuhen, Ashley K. Woods, Sean B. Joseph, H. Michael Petrassi, Case W. McNamara, Matthew S. Tremblay, Andrew I. Su, Peter G. Schultz, Arnab K. Chatterjee	125
9	A novel inhibitor of inducible NOS dimerization protects against cytokine‐induced rat beta cell dysfunction 2018 ·British Journal of Pharmacology ·Linlin Zhong, Tuan Anh Tran, Tyler D. Baguley, Sang Jun Lee, Adam Henke, (unknown), Sijia Li, Shan Yu, Fabio Arturo Grieco, Jason Roland, Peter G. Schultz, Décio L. Eizirik, Nikki Lynn Rogers, (unknown), Matthew S. Tremblay, Weijun Shen	8
10	P-262 A PDE4 Inhibitor-antibody Conjugate for Treating Ulcerative Colitis 2017 ·Inflammatory Bowel Diseases ·Shan Yu, (unknown), Reyna K. V. Lim, David T. Rodgers, Sijia Li, (unknown), (unknown), Eric Hampton, Michael J. Bollong, Jiayin Shen, (unknown), Danling Wang, Ashley Woods, Timothy M. Wright, Peter G. Schultz, Stephanie A. Kazane, Travis S. Young, Matthew S. Tremblay	1
11	Dissociated sterol‐based liver X receptor agonists as therapeutics for chronic inflammatory diseases 2016 ·The FASEB Journal ·Shan Yu, Sijia Li, Adam Henke, Evan D. Muse, Bo Cheng, Gustav Welzel, Arnab K. Chatterjee, Danling Wang, Jason Roland, Christopher K. Glass, Matthew S. Tremblay	21
12	An Immunosuppressive Antibody–Drug Conjugate 2015 ·Journal of the American Chemical Society ·Rongsheng E. Wang, Tao Liu, (unknown), Yu Cao, Jintang Du, Xiaozhou Luo, V. Deshmukh, Chan Hyuk Kim, Brian R. Lawson, Matthew S. Tremblay, Travis S. Young, Stephanie A. Kazane, Feng Wang, Peter G. Schultz	84
13	Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate 2015 ·Bioconjugate Chemistry ·Reyna K. V. Lim, Shan Yu, Bo Cheng, Sijia Li, Nam‐Jung Kim, Yu Cao, Victor Chi, (unknown), Arnab K. Chatterjee, Peter G. Schultz, Matthew S. Tremblay, Stephanie A. Kazane	51
14	A Stem Cell–Based Approach to Cartilage Repair breakdown → 2012 ·Science ·Kristen Johnson, Shoutian Zhu, Matthew S. Tremblay, Joshua N. Payette, Jianing Wang, Laure C. Bouchez, Shelly Meeusen, Alana Althage, Charles Y. Cho, Xu Wu, Peter G. Schultz	645
15	Intermolecular Energy Transfer from Tb³⁺ to Eu³⁺ in Aqueous Aggregates and on the Surface of Human Cells 2011 ·Organic Letters ·(unknown), Matthew S. Tremblay, Steffen Jockusch, Nicholas J. Turro, Dalibor Sameš	17
16	A Luminescent Sensor for Tyrosine Phosphorylation 2007 ·Organic Letters ·Matthew S. Tremblay, (unknown), Dalibor Sameš	55
17	Transposing Molecular Fluorescent Switches into the Near-IR: Development of Luminogenic Reporter Substrates for Redox Metabolism 2007 ·Journal of the American Chemical Society ·Marlin Halim, Matthew S. Tremblay, Steffen Jockusch, Nicholas J. Turro, Dalibor Sameš	69
18	Synthesis of luminescent heterometallic bis-lanthanide complexes via selective, sequential metallation 2006 ·Chemical Communications ·Matthew S. Tremblay, Dalibor Sameš	53
19	Allyl and benzyl iodides by the anomalous action of iodotrimethylsilane 2006 ·Bioorganic & Medicinal Chemistry Letters ·Qing Zhu, Matthew S. Tremblay	6
20	A New Fluorogenic Transformation: Development of an Optical Probe for Coenzyme Q 2005 ·Organic Letters ·Matthew S. Tremblay, Dalibor Sameš	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact